CAS 547756-93-4

N-(2,6-dichloropyridin-4-yl)-2-[1,3-dimethyl-4-(propan-2-yl)-1H-pyrazolo[3,4-b]pyridin-6-yl]hydrazinecarboxamide

Description:

N-(2,6-dichloropyridin-4-yl)-2-[1,3-dimethyl-4-(propan-2-yl)-1H-pyrazolo[3,4-b]pyridin-6-yl]hydrazinecarboxamide, with CAS number 547756-93-4, is a synthetic organic compound characterized by its complex structure, which includes a hydrazinecarboxamide moiety and multiple aromatic rings. This compound features a dichloropyridine group, which contributes to its potential biological activity, particularly in medicinal chemistry. The presence of a pyrazolo[3,4-b]pyridine structure suggests possible interactions with various biological targets, making it of interest in drug discovery. Its hydrazinecarboxamide functional group may also impart specific reactivity and solubility characteristics. The compound's molecular weight, solubility, and stability can vary based on environmental conditions and the presence of solvents. As with many compounds in this class, it may exhibit specific pharmacological properties, including potential anti-cancer or anti-inflammatory activities, warranting further investigation in preclinical studies. Safety and handling precautions are essential due to the presence of chlorine substituents, which can influence toxicity and environmental impact.

Formula: C₁₇H₁₉Cl₂N₇O

InChI: InChI=1/C17H19Cl2N7O/c1-8(2)11-7-14(22-16-15(11)9(3)25-26(16)4)23-24-17(27)20-10-5-12(18)21-13(19)6-10/h5-8H,1-4H3,(H,22,23)(H2,20,21,24,27)

SMILES: CC(C)c1cc(nc2c1c(C)nn2C)NNC(=Nc1cc(Cl)nc(c1)Cl)O

Synonyms:

• Hydrazinecarboxamide, N-(2,6-dichloro-4-pyridinyl)-2-[1,3-dimethyl-4-(1-methylethyl)-1H-pyrazolo[3,4-b]pyridin-6-yl]-
• N-(2,6-Dichloropyridin-4-yl)-2-(4-isopropyl-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridin-6-yl)hydrazinecarboxamide

JTE 013

CAS: 547756-93-4

JTE 013 is a medicinal compound that acts as an inhibitor of kinases, which are enzymes involved in cell cycle regulation and tumor growth. It has been shown to induce apoptosis, or programmed cell death, in cancer cells and has potential as an anticancer agent. JTE 013 has been tested on human cancer cell lines and found to be effective at inhibiting protein expression related to the growth of tumors. This compound has also been found in urine samples of Chinese patients with various forms of cancer, indicating its potential for use as a diagnostic tool. Overall, JTE 013 shows promise as a potent inhibitor of kinases for use in the treatment of cancer.

Formula: C₁₇H₁₉Cl₂N₇O

Purity: Min. 95%

Molecular weight: 408.3 g/mol

Ref: 3D-XWA75693